Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News North European Oil Royalty Trust NRT

North European Oil Royalty Trust (the Trust) is a grantor trust which, on behalf of the owners of units of beneficial interest in the Trust (the unit owners), holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The rights are held under contracts with local German exploration and development subsidiaries of... see more

Recent & Breaking News (NYSE:NRT)

North European Oil Royalty Trust Announces The Distribution For The Second Quarter Of Fiscal 2017

PR Newswire April 28, 2017

North European Oil Royalty Trust Announces Net Income And Results For The First Quarter Of Fiscal 2017

PR Newswire February 10, 2017

North European Oil Royalty Trust Announces The Distribution For The First Quarter Of Fiscal 2017

PR Newswire January 30, 2017

North European Oil Royalty Trust Announces Net Income And Results For The Fourth Quarter Of Fiscal 2016

PR Newswire November 17, 2016

Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma

PR Newswire Asia October 30, 2016

Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma

PR Newswire October 30, 2016

Novogen Licenses Phase II-Ready Molecule from Genentech for Development in Glioblastoma

PR Newswire October 30, 2016

North European Oil Royalty Trust Announces The Distribution For The Fourth Quarter Of Fiscal 2016

PR Newswire October 28, 2016

Conversion of Convertible Notes

PR Newswire Asia September 14, 2016

US FDA Approves Investigational New Drug (IND) Application for Cantrixil(TM) (TRX-E-002-1) in Ovarian Cancer

PR Newswire Asia September 11, 2016

Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in Ovarian Cancer

PR Newswire Asia August 11, 2016

Novogen Patent Covering Anisina(TM) Has Proceeded to Grant

PR Newswire June 14, 2016

Novogen Patent Covering Anisina(TM) Has Proceeded to Grant

PR Newswire Asia June 13, 2016

North European Oil Royalty Trust Announces Net Income And Results For The Second Quarter Of Fiscal 2016

PR Newswire May 13, 2016

Novogen Provides Update On Development Of Cantrixil

PR Newswire Asia May 1, 2016

North European Oil Royalty Trust Announces The Distribution For The Second Quarter Of Fiscal 2016

PR Newswire April 28, 2016

Novogen Receives R&D Tax Incentive Cash Refund

PR Newswire March 16, 2016

Novogen Patent Covering Cantrixil And Trilexium Has Proceeded To Grant

PR Newswire February 19, 2016

North European Oil Royalty Trust Announces Net Income And Results For The First Quarter Of Fiscal 2016

PR Newswire February 12, 2016

Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed

PR Newswire February 5, 2016